NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
XPO Logistics, Inc. (NYSE: XPO) Class Period: February 26, 2014 - December 12, 2018 Lead Plaintiff Deadline: February 12, 2019 Join the action: https://www.zlk.com/pslra-1/xpo-logistics-inc...orm?wire=3
The lawsuit alleges: XPO Logistics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) XPO’s highly touted aggressive M&A strategy had yielded only minimal returns to the Company; (ii) XPO was utilizing improper accounting practices to mask its true financial condition, including, inter alia, under-reporting of bad debts and aggressive amortization assumptions; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
To learn more about the XPO Logistics, Inc. class action contact jlevi@levikorsinsky.com .
DBV Technologies S.A. (NASDAQ: DBVT) Class Period: February 14, 2018 - December 19, 2018 Lead Plaintiff Deadline: March 18, 2019 Join the action: https://www.zlk.com/pslra-1/dbv-technologies-...orm?wire=3
The lawsuit alleges: DBV Technologies S.A. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the DBV Technologies S.A. class action contact jlevi@levikorsinsky.com .
Alkermes plc (NASDAQGS: ALKS) Class Period: February 17, 2017 - November 1, 2018 Lead Plaintiff Deadline: February 25, 2019 Join the action: https://www.zlk.com/pslra-1/alkermes-plc-loss-form?wire=3
The lawsuit alleges: Alkermes plc made materially false and/or misleading statements and/or failed to disclose that: (1) the FDA had advised Alkermes to follow a certain protocol in connection with its New Drug Application submission for its drug ALKS 5461; (2) Alkermes had failed to follow that protocol; (3) consequently, an FDA advisory committee voted 21 to 2 against the approval of ALKS 5461; and (4) as a result, Alkermes’ public statements were materially false and/or misleading at all relevant times.
To learn more about the Alkermes plc class action contact jlevi@levikorsinsky.com .
Markel Corporation (NYSE: MKL) Class Period: July 26, 2017 - December 6, 2018 Lead Plaintiff Deadline: March 12, 2019 Join the action: https://www.zlk.com/pslra-1/markel-corporatio...orm?wire=3
The lawsuit alleges that, during the class period, Markel Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s subsidiaries did not appropriately record loss reserves; (2) as a result, the loss reserves would need to be adjusted and/or restated; (3) these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
To learn more about the Markel Corporation class action contact jlevi@levikorsinsky.com .
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
